Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells. - Wikidata - awgldk - TriplyDB

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

http://www.wikidata.org/entity/Q35180093

about

T cell epitopes and post-translationally modified epitopes in type 1 diabetes Hands-on workshops as an effective means of learning advanced technologies including genomics, proteomics and bioinformatics B cells and type 1 diabetes ...in mice and men.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Mapping I-A(g7) restricted epitopes in murine G6PC2.Antigen targets of type 1 diabetes autoimmunity Constitutive and inflammatory immunopeptidome of pancreatic β-cells.Diabetogenic T-cell clones recognize an altered peptide of chromogranin A.Novel autoantigens in type 1 diabetes.Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes.Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.Islet antigen-specific Th17 cells can induce TNF-α-dependent autoimmune diabetes.Type 1 diabetes: primary antigen/peptide/register/trimolecular complex CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.β cell ER stress and the implications for immunogenicity in type 1 diabetes.Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes.T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.Islet stress, degradation and autoimmunity

P2860

Q26787014-DF9909E0-9DCE-4E8E-84CE-964C184298B1 Q28387396-5D396EAB-410E-49A6-AD4E-817725878478 Q33926306-4EACEDB8-71A8-47EB-B724-170337A3FCF6 Q34375578-74AE6F9C-FBA6-4182-B161-01B865B87F8F Q34415712-0B312E0A-9CFF-4136-B15F-04BBF215C6CD Q35852999-0F87917B-CE87-441E-9C20-F1CC0FE4FE4A Q36339503-89709DC0-F577-4B94-8D69-88671585276A Q36410759-8520CF6B-59D8-4F5C-8D5E-80C4DD534738 Q36881807-9AFA58A9-ABC2-4627-BC82-7AA664B52830 Q36945852-59E7F092-F69E-4C17-A997-DFC30388FE38 Q37018598-F1EE4C52-BEE0-4026-AD5B-D7D8887BF92B Q37274444-A26871BF-1FB2-4ADC-B474-B5C632A9F027 Q37598361-23E1D3DA-5E1A-4C1B-A2D3-94C687C2275C Q37606380-2A24C582-EB0E-4CDB-B3D6-FB86E93F902E Q37613441-993C82EE-D534-42A6-BEAE-2D835185B597 Q38637035-11F5DB3B-55FE-4DBC-A9B4-1C5F2E616F26 Q42369799-723C4E1D-3A8E-432B-836C-4FDE1C6817FC Q47093542-AF48B3EB-8180-4F91-AB7E-48B65BB75E19 Q51350685-6414754A-0400-4BB0-ACFF-9F3645BF84F0 Q58715113-711D60FD-519B-4E67-9E28-29E32708C50F

P2860

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

http://www.wikidata.org/entity/Q35180093

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

@ast

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

@en

type

label

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

@ast

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

@en

prefLabel

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

@ast

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

@en

P1433

Q35180093-82D2D88D-F191-4315-8964-6F870862ADE5

P1476

Q35180093-71AAF8CE-16B9-45D8-8365-AF597FC83BED

P2093

Q35180093-03C19E38-C038-4DDA-94BE-4555309E8C3C

Q35180093-1C525B45-1DDF-452E-BA48-B6E36853AD03

Q35180093-2DEA0462-9451-4447-8300-B17BE89B4D00

Q35180093-54A5A910-B39B-4FF3-83A0-789786792209

Q35180093-827CF8CF-6D6B-480C-B24A-5997273085AD

Q35180093-AC0BF167-6B29-4909-9661-D67A2A455ABC

Q35180093-B9EC2BC8-D596-40C0-9381-FC810F4A082A

Q35180093-CA6EEC58-0882-45E2-95B2-8E71CB7ADF3F

Q35180093-CE3B329A-45C9-46F1-B5CD-2D57E7766779

P2860

Q35180093-17DE7059-C062-46FE-A631-BA8EB470FFB9

Q35180093-1A968BBF-ACD1-40E1-9E92-C97D952EC4C4

Q35180093-1FB8C27E-004E-4357-9DAE-5DC2A71B2640

Q35180093-35DE53BB-DC80-4479-A953-2BC397293E1F

Q35180093-469F50FA-4AB6-4682-ACE8-F886B7654D7A

Q35180093-518D270D-9A1B-4948-9952-3F7A3094E6AB

Q35180093-6B3F6D96-2382-48D9-BC05-8DAA0E538159

Q35180093-6D5E89F2-6A36-47A8-9B75-9B2BECDF38D9

Q35180093-79B719A2-07DB-4527-BCC2-815D0A14FEFF

Q35180093-7BE9997A-D409-43B3-835E-E1F2649D36CC

P304

Q35180093-1FBAB756-7159-4404-9D4D-5F9410187E39

P31

Q35180093-F0288E93-650A-4BA0-AE75-78E7585B55CA

P356

Q35180093-32807D89-B2EB-4A16-B0CD-E6CB785E6C1A

P407

Q35180093-C997032B-F730-4A6D-821E-E151286D55E7

P433

Q35180093-74A73EB7-1A1A-4DFA-8BAC-DE2F54D95E1B

P478

Q35180093-1D7E4CF7-EA3A-44ED-88C7-8DF03BC76797

P577

Q35180093-981727B8-D0CF-443E-BFD3-C79A9DBFAC29

P5875

Q35180093-52563E49-C7C6-421A-807F-B6D6511CB1FC

P698

Q35180093-5D34DB4A-38EC-4254-BB5E-99132E89D363

P932

Q35180093-BAB862C0-BE72-47A6-8C22-7ACEC04BAA6C

P356

P1433

P1476

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

@en

P2093

Brenda Bradley

http://www.w3.org/2001/XMLSchema#string

Gene Barbour

http://www.w3.org/2001/XMLSchema#string

Kathryn Haskins

http://www.w3.org/2001/XMLSchema#string

Michael Armstrong

http://www.w3.org/2001/XMLSchema#string

Nichole Reisdorph

http://www.w3.org/2001/XMLSchema#string

Richard Reisdorph

http://www.w3.org/2001/XMLSchema#string

Rocky L Baker

http://www.w3.org/2001/XMLSchema#string

Roger L Powell

http://www.w3.org/2001/XMLSchema#string

Thomas Delong

http://www.w3.org/2001/XMLSchema#string

P2860

Chromogranin A is an autoantigen in type 1 diabetes

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

A diabetes-associated T-cell autoantigen maps to a telomeric locus on mouse chromosome 6.

Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse.

Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.

Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells.

Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes?

Secretogranin III: a bridge between core hormone aggregates and the secretory granule membrane.

P304

2325-2330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB11-0288

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51471970

http://www.w3.org/2001/XMLSchema#string

P698

21734016

http://www.w3.org/2001/XMLSchema#string

P932

3161333

http://www.w3.org/2001/XMLSchema#string